
Maharashtra FDA Cancels Cipla's Pune Warehouse Drug Licences Over Packaging, Storage & Record Violations
The story in brief
Maharashtra FDA cancelled Cipla Pharma & Life Sciences Ltd's Pune warehouse drug licences due to alleged packaging, storage, and record violations. The cancellation follows fresh proceedings ordered by the Bombay High Court, citing unauthorised claims on Reactin Plus packaging and deficiencies in warehouse management. The decision impacts regional medicine supply and healthcare services.